Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

Tanja Fehm*, Sven Becker, Silke Duerr-Stoerzer, Karl Sotlar, Volkmar Mueller, Diethelm Wallwiener, Nancy Lane, Erich Solomayer and Jonathan Uhr

Breast Cancer Research 2007, 9:R74 doi:10.1186/bcr1783

Accesses  

  • Last 30 days: 72 accesses
  • Last year: 999 accesses
  • All time: 6499 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

Tanja Fehm, Oliver Hoffmann, Bahriye Aktas, Sven Becker, Erich F Solomayer, Diethelm Wallwiener, Rainer Kimmig, Sabine Kasimir-Bauer Breast Cancer Research 2009, 11:R59 (10 August 2009)

Research article   Open Access Highly Accessed

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

Bahriye Aktas, Mitra Tewes, Tanja Fehm, Siegfried Hauch, Rainer Kimmig, Sabine Kasimir-Bauer Breast Cancer Research 2009, 11:R46 (9 July 2009)